Company intelligence / Profile preview

Optrex

Slough, Berkshire, United Kingdom

Ownership: Private
Development stage: Other

Overview

Optrex is a UK eye-care company and consumer health brand focused on over-the-counter ophthalmic products for common eye conditions. Its portfolio includes eye drops, eye washes, sprays, and related therapeutic eye-care products used for dry, irritated, itchy, watery, bloodshot, and infected eyes. The business appears to operate as Optrex Limited in the UK and is part of Reckitt’s consumer health portfolio. Optrex is not a biotech drug developer; it is a commercial-stage healthcare brand centered on retail eye-care products rather than a clinical R&D pipeline.

Therapeutic areas: Ophthalmology
Modalities: Small moleculeDevice
Industry: Consumable Medical Devices

Beyond the preview

Go deeper on Optrex.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Optrex.

Explore the full profile